Ilya Pharma presenting at Hybrid event BIO CEO Investor conference in NYC 14-17 February 2022
Largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.
Abstract: "The ILP-technology platform is scalable and enables efficient delivery of immunoregulatory proteins locally on-site – lead program in clinical phase 2 developments"